Free Trial

MBX Biosciences (MBX) Institutional Ownership

MBX Biosciences logo
$10.48 -0.02 (-0.14%)
As of 12:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)

Number of
Institutional Buyers
(last 12 months)
39
Total
Institutional Inflows
(last 12 months)
$414.27M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$6.01M
Get MBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MBX Institutional Buying and Selling by Quarter

MBX Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2025Alps Advisors Inc.26,034$192K0.0%-3.6%0.078%
4/28/2025 Aaron Wealth Advisors LLC50,000$369K0.0%N/A0.150%
3/24/2025Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.705%
2/17/2025Woodline Partners LP608,721$11.22M0.1%+17.1%1.821%
2/17/2025Parkman Healthcare Partners LLC170,000$3.13M0.4%N/A0.509%
2/17/2025Nuveen Asset Management LLC14,471$267K0.0%N/A0.043%
2/17/2025Millennium Management LLC333,642$6.15M0.0%-24.2%0.998%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,335$117K0.0%N/A0.019%
2/17/2025Deutsche Bank AG4,338$80K0.0%N/A0.013%
2/17/2025Driehaus Capital Management LLC1,581,760$29.15M0.2%+61.2%4.733%
2/17/2025Citadel Advisors LLC220,330$4.06M0.0%+62.5%0.659%
2/17/2025Bank of America Corp DE16,059$296K0.0%N/A0.048%
2/17/2025BNP Paribas Financial Markets1,486$27K0.0%N/A0.004%
2/17/2025Alyeska Investment Group L.P.174,700$3.22M0.0%-22.4%0.523%
2/14/2025Schonfeld Strategic Advisors LLC71,500$1.32M0.0%N/A0.214%
2/14/2025Northern Trust Corp90,682$1.67M0.0%N/A0.271%
2/14/2025The Manufacturers Life Insurance Company 49,675$916K0.0%+7.5%0.149%
2/14/2025Virtus ETF Advisers LLC3,468$64K0.0%N/A0.010%
2/14/2025Price T Rowe Associates Inc. MD1,161,527$21.41M0.0%-2.6%3.476%
2/14/2025MetLife Investment Management LLC7,230$133K0.0%N/A0.022%
2/13/2025Marshall Wace LLP25,900$477K0.0%+115.8%0.077%
2/13/2025Wells Fargo & Company MN5,844$108K0.0%N/A0.017%
2/12/2025Geode Capital Management LLC265,703$4.90M0.0%+1,093.2%0.795%
2/12/2025Franklin Resources Inc.369,300$6.81M0.0%-17.9%1.105%
2/12/2025Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.706%
2/12/2025Norges Bank25,000$461K0.0%N/A0.075%
2/12/2025BIT Capital GmbH12,743$235K0.0%N/A0.038%
2/12/2025JPMorgan Chase & Co.9,106$168K0.0%N/A0.027%
2/11/2025Corebridge Financial Inc.5,593$103K0.0%N/A0.017%
2/11/2025Platinum Investment Management Ltd.162,090$2.99M0.2%+8.1%0.485%
2/6/2025Charles Schwab Investment Management Inc.93,311$1.72M0.0%N/A0.279%
2/4/2025 Bank of New York Mellon Corp23,914$441K0.0%N/A0.072%
1/30/2025 Rhumbline Advisers9,472$175K0.0%N/A0.028%
11/27/2024Franklin Resources Inc.450,000$11.69M0.0%N/A1.347%
11/19/2024Barclays PLC16,400$426K0.0%N/A0.049%
11/18/2024Teachers Retirement System of The State of Kentucky26,708$694K0.0%N/A0.080%
11/16/2024Geode Capital Management LLC22,269$579K0.0%N/A0.067%
11/15/2024Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909%
11/15/2024Barclays PLC16,400$426K0.0%N/A0.049%
11/15/2024Jane Street Group LLC26,570$690K0.0%N/A0.080%
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791%
11/15/2024Soros Fund Management LLC30,000$779K0.0%N/A0.090%
11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522%
11/15/2024Point72 DIFC Ltd24,011$624K0.0%N/A0.072%
11/15/2024Point72 Asset Management L.P.15,600$405K0.0%N/A0.047%
11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150%
11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032%
11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816%
11/13/2024The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138%
(Data available from 1/1/2016 forward)

MBX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MBX shares?

During the previous two years, 43 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($155.50M), NEA Management Company LLC ($93.90M), Wellington Management Group LLP ($52.99M), RA Capital Management L.P. ($39.26M), Driehaus Capital Management LLC ($29.15M), Price T Rowe Associates Inc. MD ($21.41M), and Woodline Partners LP ($11.22M).Learn more on MBX's institutional investors.

Which institutional investors have been buying MBX Biosciences stock?

Of the 39 institutional investors that purchased MBX Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), Driehaus Capital Management LLC ($600.44K), Franklin Resources Inc. ($450K), and Geode Capital Management LLC ($265.70K).

How much institutional buying is happening at MBX Biosciences?

Institutional investors have bought a total of 16,451,541 shares in the last 24 months. This purchase volume represents approximately $414.27M in transactions.

Which MBX Biosciences major shareholders have been selling company stock?

The following institutional investors have sold MBX Biosciences stock in the last 24 months: Millennium Management LLC ($106.77K), Franklin Resources Inc. ($80.70K), Wellington Management Group LLP ($56.43K), Alyeska Investment Group L.P. ($50.30K), Price T Rowe Associates Inc. MD ($31.41K), and Alps Advisors Inc. ($986.00).

How much institutional selling is happening at MBX Biosciences?

Institutional investors have sold a total of 326,594 shares in the last 24 months. This volume of shares sold represents approximately $6.01M in transactions.



This page (NYSE:MBX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners